Other languages Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
54.65 ^CNY	+0.94%		+0.09%	+4.39%

Apr. 22	Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22
China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	Mar. 18
Xiamen Amoytop Biotech Gets Nod to Market Hepatitis Drug; Shares Up 4%	Mar. 18
Amoytop Biotech's 2023 Profit Jumps 93%	Feb. 26
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23
'Hawkish' China military squeeze on Taiwan likely after election	Jan. 03
Taiwan not seeing signs of large-scale Chinese military activity pre-election	Dec. 25
Taiwan to 'handle' spate of Chinese balloons based on threat level	Dec. 20
Taiwan reports more suspected Chinese weather balloons crossing Taiwan Strait	Dec. 17
Xiamen Amoytop Biotech Co., Ltd.(SHSE:688278) added to Shanghai Stock Exchange Health Care Sector Index	Dec. 11
Amoytop Biotech Signs Exclusive License Deal for Liver Disease Drug With Alphamab Unit	Dec. 07
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-19
Taiwan raises concerns about situation 'getting out of hand' with China drills	23-09-22
Xiamen Amoytop Biotech Co., Ltd.(XSSC:688278) added to S&P Global BMI Index	23-09-18
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17
Amoytop Biotech Signs Exclusive Commercialization Deal With Fosun Unit	23-06-01
Sector Update: Health Care Stocks Edge Higher Premarket Monday	23-05-15
Top Premarket Gainers	23-05-15
Aligos Therapeutics to Collaborate with Xiamen Amoytop Biotech on Liver Disease Treatments; Aligos Shares Jump	23-05-15
Huihe Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Prosperico Ventures Co., Ltd., Shenzhen Capital Group Co., Ltd., Jolmo Investment Management Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	23-05-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

Other languages

Filters